Gamma‐glutamyl transferase and the risk of all‐cause and disease‐specific mortality in patients with diabetes: A nationwide cohort study

Author:

Chung Goh Eun1,Jeong Su‐Min2,Yu Su Jong3,Yoo Jeong‐Ju4ORCID,Cho Yuri5,Lee Kyu‐na6,Shin Dong Wook27,Kim Yoon Jun1,Yoon Jung‐Hwan1,Han Kyungdo8,Cho Eun Ju3ORCID

Affiliation:

1. Department of Internal Medicine and Healthcare Research Institute Seoul National University Hospital Healthcare System Gangnam Center Seoul Republic of Korea

2. Department of Medicine Seoul National University College of Medicine Seoul Republic of Korea

3. Department of Internal Medicine and Liver Research Institute Seoul National University College of Medicine Seoul Republic of Korea

4. Department of Internal Medicine, Division of Gastroenterology and Hepatology Soonchunhyang University Bucheon Hospital Gyeonggi‐do Republic of Korea

5. Center for Liver and Pancreatobiliary Cancer National Cancer Center Goyang Republic of Korea

6. Department of Biomedicine & Health Science The Catholic University of Korea Seoul Korea

7. Department of Clinical Research Design and Evaluation/Department of Digital Health Samsung Advanced Institute for Health Science Seoul Republic of Korea

8. Department of Biostatistics College of Medicine, Soongsil University Seoul Republic of Korea

Abstract

AbstractBackgroundThere exists a paucity of data regarding whether gamma‐glutamyl transferase is associated with disease‐specific mortality in patients with type 2 diabetes mellitus. This study aimed to investigate the association of serum gamma‐glutamyl transferase levels with all‐cause and disease‐specific mortality in patients with diabetes mellitus using a Korean nationwide health‐screening database.MethodsA total of 9 687 066 patients without viral hepatitis or liver cirrhosis who underwent health examination in 2009 were included. These patients were divided into four groups according to sex‐specific quartiles of serum gamma‐glutamyl transferase levels.ResultsDuring a median follow‐up period of 8.1 years, 222 242 deaths were identified. The all‐cause mortality rate increased as the serum gamma‐glutamyl transferase levels became higher (highest quartile vs lowest quartile: hazard ratio [HR], 1.57; 95% confidence interval [CI], 1.55–1.59; p for trend <.001). Similar trends were observed for cardiovascular disease (HR, 1.57; 95% CI, 1.53–1.62), ischemic heart disease (HR, 1.40; 95% CI, 1.33–1.48), and stroke (HR, 1.72; 95% CI, 1.60–1.85) in the highest quartile, as compared with the lowest quartile (p for trend <.001). As the gamma‐glutamyl transferase quartiles became higher, mortality rates related to cancer (HR, 1.56; 95% CI, 1.52–1.60), liver disease (HR, 9.42; 95% CI, 8.81–10.07), respiratory disease (HR, 1.55; 95% CI, 1.49–1.62), and infectious disease (HR, 1.73; 95% CI, 1.59–1.87) also increased in the highest quartile, compared with the lowest quartile (p for trend <.001).ConclusionsSerum gamma‐glutamyl transferase levels may be useful for the risk assessment of all‐cause and disease‐specific mortality among patients with type 2 diabetes mellitus.image

Funder

Seoul National University Hospital

Publisher

Wiley

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3